Home › Funds › Triodos Investment Management BV › RMD

Triodos Investment Management BV position in RMD

RESMED INC · Health Care

Triodos Investment Management BV reported holding 191,400 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$42.3M, representing 2.59% of its reported portfolio and ranking #14 among its reported holdings. Triodos Investment Management BV has disclosed RMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)191.40K sh
Reported value held$42.32M
Portfolio Weight2.59%
First reportedQ1 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Triodos Investment Management BV's RMD position evolved

Triodos Investment Management BV first disclosed a stake in RMD in Q1 2024 at 114,500 shares (US$22.7M). The position peaked in Q3 2026 at 191,400 shares, worth US$42.3M. Across 11 filings, Triodos Investment Management BV increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 191,400 shares valued at US$42.3M — an increase of 49,400 shares quarter over quarter.. Notable position changes include a 35% increase in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 114.50K $22.67M New
Q2 2024 131.80K $25.23M Add
Q3 2024 135.20K $33.01M Add
Q4 2024 135.20K $30.92M Hold
Q1 2025 134.40K $29.56M Reduce
Q2 2025 121.70K $31.40M Reduce
Q3 2025 120.60K $33.01M Reduce
Q4 2025 120.60K $29.32M Hold
Q1 2026 119.10K $26.74M Reduce
Q2 2026 142.00K $27.67M Add
Q3 2026 191.40K $42.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RMD and 13F data

RMD (RESMED INC) is a Health Care company. 31 other funds we track also report a position in RMD — the largest reported positions include Ilex Capital Partners (UK) LLP (US$163.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RMD

All RMD fund holders →

FAQ

How long has Triodos Investment Management BV held RMD?

Triodos Investment Management BV has disclosed RMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Triodos Investment Management BV's current position in RMD?

As of Q3 2026, Triodos Investment Management BV holds 191.40K shares of RMD (RESMED INC), valued at $42.32M, representing 2.59% of its reported portfolio and ranking #14.

Has Triodos Investment Management BV been buying or selling RMD?

In the latest 13F filing (Q3 2026), Triodos Investment Management BV increased its position in RMD. The position peaked in Q3 2026 at 191.40K shares.

Which other funds hold RMD?

Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.